These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 18443198

  • 1. Activation of peroxisome proliferator-activated receptor beta/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1/2.
    Rodríguez-Calvo R, Serrano L, Coll T, Moullan N, Sánchez RM, Merlos M, Palomer X, Laguna JC, Michalik L, Wahli W, Vázquez-Carrera M.
    Diabetes; 2008 Aug; 57(8):2149-57. PubMed ID: 18443198
    [Abstract] [Full Text] [Related]

  • 2. Activation of peroxisome proliferator-activated receptor-β/-δ (PPAR-β/-δ) ameliorates insulin signaling and reduces SOCS3 levels by inhibiting STAT3 in interleukin-6-stimulated adipocytes.
    Serrano-Marco L, Rodríguez-Calvo R, El Kochairi I, Palomer X, Michalik L, Wahli W, Vázquez-Carrera M.
    Diabetes; 2011 Jul; 60(7):1990-9. PubMed ID: 21617181
    [Abstract] [Full Text] [Related]

  • 3. The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells.
    Serrano-Marco L, Barroso E, El Kochairi I, Palomer X, Michalik L, Wahli W, Vázquez-Carrera M.
    Diabetologia; 2012 Mar; 55(3):743-51. PubMed ID: 22179221
    [Abstract] [Full Text] [Related]

  • 4. PPARβ/δ ameliorates fructose-induced insulin resistance in adipocytes by preventing Nrf2 activation.
    Barroso E, Rodríguez-Rodríguez R, Chacón MR, Maymó-Masip E, Ferrer L, Salvadó L, Salmerón E, Wabistch M, Palomer X, Vendrell J, Wahli W, Vázquez-Carrera M.
    Biochim Biophys Acta; 2015 May; 1852(5):1049-58. PubMed ID: 25728706
    [Abstract] [Full Text] [Related]

  • 5. The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1.
    Barroso E, Eyre E, Palomer X, Vázquez-Carrera M.
    Biochem Pharmacol; 2011 Feb 15; 81(4):534-43. PubMed ID: 21146504
    [Abstract] [Full Text] [Related]

  • 6. Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells.
    Coll T, Alvarez-Guardia D, Barroso E, Gómez-Foix AM, Palomer X, Laguna JC, Vázquez-Carrera M.
    Endocrinology; 2010 Apr 15; 151(4):1560-9. PubMed ID: 20185762
    [Abstract] [Full Text] [Related]

  • 7. Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes.
    Planavila A, Rodríguez-Calvo R, Jové M, Michalik L, Wahli W, Laguna JC, Vázquez-Carrera M.
    Cardiovasc Res; 2005 Mar 01; 65(4):832-41. PubMed ID: 15721863
    [Abstract] [Full Text] [Related]

  • 8. PPARbeta/delta agonist stimulates human lung carcinoma cell growth through inhibition of PTEN expression: the involvement of PI3K and NF-kappaB signals.
    Han S, Ritzenthaler JD, Zheng Y, Roman J.
    Am J Physiol Lung Cell Mol Physiol; 2008 Jun 01; 294(6):L1238-49. PubMed ID: 18390835
    [Abstract] [Full Text] [Related]

  • 9. PPARβ/δ agonist GW501516 inhibits TNFα-induced repression of adiponectin and insulin receptor in 3T3-L1 adipocytes.
    Kim WJ, Lee W, Jung Y, Jang HJ, Kim YK, Kim SN.
    Biochem Biophys Res Commun; 2019 Mar 19; 510(4):621-628. PubMed ID: 30739791
    [Abstract] [Full Text] [Related]

  • 10. TNF-α inhibits PPARβ/δ activity and SIRT1 expression through NF-κB in human adipocytes.
    Serrano-Marco L, Chacón MR, Maymó-Masip E, Barroso E, Salvadó L, Wabitsch M, Garrido-Sánchez L, Tinahones FJ, Palomer X, Vendrell J, Vázquez-Carrera M.
    Biochim Biophys Acta; 2012 Sep 19; 1821(9):1177-85. PubMed ID: 22683888
    [Abstract] [Full Text] [Related]

  • 11. PPARβ/δ attenuates hepatic fibrosis by reducing SMAD3 phosphorylation and p300 levels via AMPK in hepatic stellate cells.
    Zhang M, Barroso E, Peña L, Rada P, Valverde ÁM, Wahli W, Palomer X, Vázquez-Carrera M.
    Biomed Pharmacother; 2024 Oct 19; 179():117303. PubMed ID: 39153437
    [Abstract] [Full Text] [Related]

  • 12. Comparison of PPAR Ligands as Modulators of Resolution of Inflammation, via Their Influence on Cytokines and Oxylipins Release in Astrocytes.
    Chistyakov DV, Astakhova AA, Goriainov SV, Sergeeva MG.
    Int J Mol Sci; 2020 Dec 16; 21(24):. PubMed ID: 33339154
    [Abstract] [Full Text] [Related]

  • 13. PPARβ/δ activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells.
    Alvarez-Guardia D, Palomer X, Coll T, Serrano L, Rodríguez-Calvo R, Davidson MM, Merlos M, El Kochairi I, Michalik L, Wahli W, Vázquez-Carrera M.
    Biochim Biophys Acta; 2011 Feb 16; 1811(2):59-67. PubMed ID: 21070867
    [Abstract] [Full Text] [Related]

  • 14. Nuclear factor-kappaB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy.
    Planavila A, Laguna JC, Vázquez-Carrera M.
    J Biol Chem; 2005 Apr 29; 280(17):17464-71. PubMed ID: 15728586
    [Abstract] [Full Text] [Related]

  • 15. Both adiponectin and interleukin-10 inhibit LPS-induced activation of the NF-κB pathway in 3T3-L1 adipocytes.
    Lira FS, Rosa JC, Pimentel GD, Seelaender M, Damaso AR, Oyama LM, do Nascimento CO.
    Cytokine; 2012 Jan 29; 57(1):98-106. PubMed ID: 22047972
    [Abstract] [Full Text] [Related]

  • 16. Agonist-induced activation releases peroxisome proliferator-activated receptor beta/delta from its inhibition by palmitate-induced nuclear factor-kappaB in skeletal muscle cells.
    Jové M, Laguna JC, Vázquez-Carrera M.
    Biochim Biophys Acta; 2005 May 01; 1734(1):52-61. PubMed ID: 15866483
    [Abstract] [Full Text] [Related]

  • 17. Atorvastatin prevents peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) downregulation in lipopolysaccharide-stimulated H9c2 cells.
    Planavila A, Sánchez RM, Merlos M, Laguna JC, Vázquez-Carrera M.
    Biochim Biophys Acta; 2005 Sep 15; 1736(2):120-7. PubMed ID: 16139565
    [Abstract] [Full Text] [Related]

  • 18. The PPARβ/δ activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1α-Lipin 1-PPARα pathway leading to increased fatty acid oxidation.
    Barroso E, Rodríguez-Calvo R, Serrano-Marco L, Astudillo AM, Balsinde J, Palomer X, Vázquez-Carrera M.
    Endocrinology; 2011 May 15; 152(5):1848-59. PubMed ID: 21363937
    [Abstract] [Full Text] [Related]

  • 19. Activation of peroxisome proliferator-activated receptor beta/delta induces lung cancer growth via peroxisome proliferator-activated receptor coactivator gamma-1alpha.
    Han S, Ritzenthaler JD, Sun X, Zheng Y, Roman J.
    Am J Respir Cell Mol Biol; 2009 Mar 15; 40(3):325-31. PubMed ID: 18776129
    [Abstract] [Full Text] [Related]

  • 20. PPARβ/δ prevents endoplasmic reticulum stress-associated inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism.
    Salvadó L, Barroso E, Gómez-Foix AM, Palomer X, Michalik L, Wahli W, Vázquez-Carrera M.
    Diabetologia; 2014 Oct 15; 57(10):2126-35. PubMed ID: 25063273
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.